Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS7059348 B2
Publication typeGrant
Application numberUS 10/438,282
Publication dateJun 13, 2006
Filing dateMay 13, 2003
Priority dateMay 13, 2002
Fee statusPaid
Also published asUS20050197652, US20060129138
Publication number10438282, 438282, US 7059348 B2, US 7059348B2, US-B2-7059348, US7059348 B2, US7059348B2
InventorsAvtar S. Nat
Original AssigneeFluidigm Corporation
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Drug delivery system
US 7059348 B2
Abstract
An implantable drug delivery system has a housing, a collapsible reservoir, a microfabricated flow channel, and at least one magnet. The collapsible reservoir is disposed in the housing. The microfabricated flow channel is connected at one end to the collapsible reservoir and opens at an external surface of the housing. The magnet is disposed within the housing adjacent a membrane defining the flow channel and is movable in response to a magnetic force to deflect the membrane into the flow channel for inhibiting drug flow from the collapsible reservoir to the external surface of the housing, and for pumping drug flow from the collapsible reservoir to the external surface of the housing.
Images(6)
Previous page
Next page
Claims(7)
1. An implantable drug delivery system, comprising:
a housing;
a collapsible reservoir disposed in the housing;
a microfabricated flow channel connected at one end to the collapsible reservoir, and further opening at an external surface of the housing;
at least one magnet disposed within the housing adjacent a membrane defining the flow channel, the magnet being movable in response to a magnetic force to deflect the membrane into the flow channel for inhibiting drug flow from the collapsible reservoir to the external surface of the housing, and for pumping drug flow from the collapsible reservoir to the external surface of the housing,
wherein the at least one magnetic comprises:
three magnets disposed adjacent the membrane, the three magnets being capable of sequential activation, each collapsing the flow channel in a region adjacent thereto, thereby peristaltically pumping the drug through the flow channel.
2. The implantable drug delivery system recited in claim 1, further comprising an electromagnet disposed within the housing to provide the magnetic force.
3. The implantable drug delivery system recited in claim 2, further comprising a power source disposed within the housing and coupled with the electromagnet.
4. The implantable drug delivery system recited in claim 1, wherein a wall of the collapsible reservoir is adapted to collapse in response to vacuum that is created as drug is depleted from the reservoir and to take up space formely occupied by an expelled amount of drug.
5. The implantable drug delivery system recited in claim 1, further comprising an electromagnet disposed within the housing to provide the magnetic force.
6. The implantable drug delivery system recited in claim 5, further comprising a power source disposed within the housing and coupled with the electromagnet.
7. The implantable drug delivery system recited in claim 1, wherein a wall of the collapsible reservoir is adapted to collapse in response to vacuum that is created as drug is depleted from the reservoir and to take up space formely occupied by an expelled amount of drug.
Description
CROSS REFERENCE TO RELATED APPLICATION

This application is a nonprovisional of, and claims the benefit of the filing date of U.S. Provisional Appl. No. 60/380,784, entitled “DRUG DELIVERY SYSTEM,” filed May 13, 2002 by Avtar S. Nat, the entire disclosure of which is incorporated herein by reference for all purposes.

The various drug delivery systems disclosed herein are ideally suited for use with, and preferably incorporates various microfabricated pump and valve systems as disclosed in U.S. Patent Applications Ser. Nos. 60/186,856, filed Mar. 3, 2000; 60/147,199, filed Aug. 3, 1999; 60/141,503, filed Jun. 28, 1999 and Ser. No. 09/605,520, filed Jun. 27, 2000.

Part I—an Implantable Drug Delivery Device

An exemplary embodiment of an implantable drug delivery device is shown in FIG. 1. It consists of a implant, (which may preferably be cylindrical in shape) which preferably also comprises the following features.

  • 1. A protective outer housing that prevents any deformation of the structure during implantation and in-use life.
  • 2. A pre-filled drug reservoir that opens into one or more delivery micro flow channels
  • 3. A battery operated pump module with flow control logic.

The protective housing can be made from any biologically inert material that will prevent buckling of the drug reservoir during implantation and while the delivery system is in use. The delivery end of this housing has openings (which may in a exemplary aspect be circular or rectangular) to allow the micro flow channels (which are connected to the drug reservoir) to discharge the drug into the patient's body. The circular area of the protective housing may be solid. The drug-reservoir end of the housing preferably has one or more circular openings or an optional mesh-like structure to both protect the drug reservoir during handling, implantation, and use, and to allow the reservoir wall to collapse when drug has been depicted from it. An example of a biologically inert material is titanium.

An advantage of having a collapsible drug reservoir is that, as the drug is pumped out of the reservoir (by the present microfabricated pump/vale system), a negative pressure is not created in the drug reservoir.

The drug reservoir and micro flow channels are created as an integrated, monolithic structure using soft lithography from any of the elastomers that are compatible with a specific drug, and according to any of the systems set forth in U.S. Patent Applications Ser. Nos. 60/186,856, filed Mar. 3, 2000; 60/147,199, filed Aug. 3, 1999; 60/141,503, filed Jun. 28, 1999 and Attorney Docket No. 20174-00230, filed Jun. 27, 2000.

The delivery end of the micro channels (through which the drug is pumped from the drug reservoir to the surface of the device) may be terminated with any suitable valve structure, for example a duck bill narrow diameter valve or a flap valve. These valves will normally remain closed and will open under the fluid pressure of the drug during expulsion from the micro flow channels. The present integrated, monolithic structure also houses several micro magnets that are located alongside of membranes that serve as shut off valves for the micro flow channels.

The battery operated pump module with flow control logic consists of a cylindrical structure that includes a battery, a programmable IC chip, and several electromagnets. The pump module is hermetically sealed and is assembled with the drug reservoir prior to encapsulation within the protective housing. The pumping dynamics will determine the flow rate within each micro flow channel and the total delivery rate is determined by the number of micro flow channels.

Depending on the program logic, the implantable drug delivery system can provide controlled release, pulsatile delivery, or programmable delivery (such as delivery only at certain times of day, or only on certain days). The size of the drug reservoir will determine the total amount of drug delivered and the duration of such delivery. In a preferred aspect of the present invention, as the drug is depleted from the reservoir, one wall of the reservoir collapses due to the vacuum that is created and takes up the space formerly occupied by the expelled amount of drug, in a manner similar to a bag of IV solution.

In optional aspects of the invention, the exit of the micro channels could also be terminated with a micro bore tubing which extends from the device, acting as a catheter for delivery to a site that may be hard or undesirable to access with the implantable drug delivery system (ie: a site where it is difficult to position the implantable drug delivery system).

The implantable drug delivery system described above could also optionally be positioned external to the body and connected by way of a micro bore catheter to deliver the drug to specific site within the body.

FIGS. 3, 4 and 5 illustrate an exemplary system of operation of the present device. As seen in FIG. 3, (and the breakaway close-up view of FIG. 4) a plurality of electromagnets EL1, EL2 and EL3 are provided. When electromagnets EL1, EL2 and EL3 are energized (under control of the IC Circuit of FIG. 1 and with power from the battery of FIG. 1) magnets M1, M2 and M3 move in radial directions D1, as shown.

In a preferred aspect of the present invention, the electromagnets EL1, EL2 and EL3 are activated in sequence (FIG. 5 shows only EL3 activated, pushing M3 in direction D1, thereby pinching off flow through the flow channel passing from the drug reservoir into the patient's body such that the drug is peristaltically pumped through the flow channel into the patient's body.

It is to be understood that peristaltic pumping can be achieved by magnetic actuation (as illustrated in FIGS. 1, 3, 4 and 5, and also by pneumatic actuation, as described in U.S. Patent Applications Ser. Nos. 60/186,856, filed Mar. 3, 2000, 60/147,199, filed Aug. 3, 1999; 60/141,503, filed Jun. 28, 1999 and filed Jun. 27, 2000. In an example of pneumatic actuation, at least 3 control channels (which arc disposed adjacent the flow channel, crossing over the flow channel such that an elastomeric membrane disposed therebetween is deflected into the flow channel when the control channel(s) are pressurized) can also be used to peristaltically pump fluid through the flow channel. In addition to pneumatic and magnetic actuation, electrostatic actuation is also contemplated. For example, as shown in FIG. 6 (and the break away close up of FIG. 7), opposite electroded surfaces E1 and E2 may be energized such that they repel one another, and thereby move apart from one another, causing E1 to deflect into the flow channel.

In the various aspects of the invention in which magnets M or electroded surfaces E are used for peristaltic pumping, the present structure preferably comprises a multi-layer elastomeric block, with a portion of the elastomeric block comprising a membrane which either separates the control channel from the flow channel, or separates a portion of the elastomeric block in which a magnet M or an electroded surface E, thereby permitting movement of the portion of the block comprising magnet M or an electroded surface E into the flow channel.

Part II—Transdermal Delivery of Medicinal Agents

In another aspect of the invention, a monolithic microfabricated pump/valve system can be used to deliver a medicinal agent through the stratum corneum of the skin, akin to a transdermal patch. In this aspect of the present invention, the present system is placed at an external location on the patient's body and the system delivers drugs directly to the surface of the patient. The drug(s) then diffuse into the patient's body through the stratum corneum. Various optional techniques are available to enhance the transport rate through the skin barrier. These include, for example, the use of permeation enhancers and/or the disruption of the stratum corneum by mechanical or other means.

The present transdermal delivery system can also be used to meter precise amounts of a drug for delivery at a predetermined rate and/or delivery profile. This rate of delivery could be modified as desired. An exemplary embodiment of such a device would he similar to the implantable device shown in FIG. 1, however, the aspect ratio could be such that the diameter of the cylinder is instead much larger than the height of the device such that the system can be easily worn like a transdermal patch on the skin.

Part III—Transdermal Body Fluid Sampling and Diagnosis

FIG. 2 illustrates a transdermal body fluid sampling device in accordance with the present invention. One exemplary use of such a device would be to measure glucose in interstitial body fluids to determine when and if to deliver insulin in diabetes management. In one embodiment of such a device, a thin gel layer is located underneath an array of micro channels that lead to a single flow channel (which is in turn connected to the drug reservoir). Within this larger channel is a sensor that measures the amount of glucose in interstitial body fluid.

Upon actuation, the larger flow channel will create a vacuum that will assist the flow of IBF into the array of micro channels and then allow it to flow past a sensor located inside the larger channel. The sensor will measure the amount of glucose and display the results.

The present invention also comprises systems which combine a sampling system with a drug delivery system (and link them to provide sensing-loop controlled drug delivery). In the case of insulin delivery, for example, this would be a tremendous benefit in diabetes management.

Part IV—Exemplary Drugs

In accordance with the present invention, any suitable drug may be dispensed. This list of drugs includes, but is not limited to the following:

Therapeutic Drugs:

  • Central Nervous System
  • Cardiovascular
  • Inner Ear
  • Oncology
  • Ocular
  • Tissue Engineering
  • Neurological
  • Inner Cranial
  • Rheumatoid Arthritis
  • Parkinson's Diseases
  • Contraception
  • Anti-Epileptics
  • Anemia
  • Diabetes
  • Multiple Sclerosis
  • Schizophrenia
  • AIDS Infections
    Other:
  • Chemical Make-up
  • Small Molecule
  • Protein (large molecule)
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4373527 *Apr 27, 1979Feb 15, 1983The Johns Hopkins UniversityImplantable, programmable medication infusion system
US5665070 *Jan 19, 1995Sep 9, 1997I-Flow CorporationInfusion pump with magnetic bag compression
US6408878 *Feb 28, 2001Jun 25, 2002California Institute Of TechnologyMicrofabricated elastomeric valve and pump systems
US6520936 *Jun 8, 2000Feb 18, 2003Medtronic Minimed, Inc.Method and apparatus for infusing liquids using a chemical reaction in an implanted infusion device
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8021480Apr 16, 2010Sep 20, 2011California Institute Of TechnologyMicrofluidic free interface diffusion techniques
US8048378Nov 1, 2011Fluidigm CorporationOptical lens system and method for microfluidic devices
US8052792May 15, 2007Nov 8, 2011California Institute Of TechnologyMicrofluidic protein crystallography techniques
US8058630Jan 15, 2010Nov 15, 2011Fluidigm CorporationMicrofluidic devices and methods
US8104515Aug 13, 2009Jan 31, 2012California Institute Of TechnologyMicrofabricated elastomeric valve and pump systems
US8105550Dec 22, 2009Jan 31, 2012Fluidigm CorporationMethod and system for microfluidic device and imaging thereof
US8105824Jan 10, 2011Jan 31, 2012Fluidigm CorporationIntegrated chip carriers with thermocycler interfaces and methods of using the same
US8124218Sep 9, 2009Feb 28, 2012California Institute Of TechnologyMicrofabricated elastomeric valve and pump systems
US8148078Sep 8, 2008Apr 3, 2012Fluidigm CorporationCopy number variation determination, methods and systems
US8152136 *Nov 26, 2007Apr 10, 2012The Hong Kong Polytechnic UniversityPolymer microvalve with actuators and devices
US8157434Jan 22, 2008Apr 17, 2012Fluidigm CorporationHigh efficiency and high precision microfluidic devices and methods
US8163492Aug 17, 2010Apr 24, 2012Fluidign CorporationMicrofluidic device and methods of using same
US8206593Dec 5, 2005Jun 26, 2012Fluidigm CorporationMicrofluidic chemical reaction circuits
US8220487Nov 1, 2007Jul 17, 2012California Institute Of TechnologyMicrofabricated elastomeric valve and pump systems
US8220494Aug 10, 2004Jul 17, 2012California Institute Of TechnologyMicrofluidic large scale integration
US8247178Aug 21, 2012Fluidigm CorporationThermal reaction device and method for using the same
US8257666Feb 8, 2012Sep 4, 2012California Institute Of TechnologyIntegrated active flux microfluidic devices and methods
US8273574Feb 14, 2011Sep 25, 2012California Institute Of TechnologyApparatus and methods for conducting assays and high throughput screening
US8282896Oct 5, 2009Oct 9, 2012Fluidigm CorporationDevices and methods for holding microfluidic devices
US8287495Oct 10, 2011Oct 16, 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8298184Oct 30, 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8343442Aug 18, 2010Jan 1, 2013Fluidigm CorporationMicrofluidic device and methods of using same
US8367016Jan 27, 2012Feb 5, 2013Fluidigm CorporationMethod and system for microfluidic device and imaging thereof
US8388822Mar 22, 2012Mar 5, 2013California Institute Of TechnologyMethod and apparatus for analysis and sorting of polynucleotides based on size
US8389960Nov 11, 2011Mar 5, 2013Fluidigm CorporationMicrofluidic devices and methods
US8408421Oct 29, 2008Apr 2, 2013Tandem Diabetes Care, Inc.Flow regulating stopcocks and related methods
US8420017Aug 31, 2010Apr 16, 2013Fluidigm CorporationMicrofluidic reaction apparatus for high throughput screening
US8426159Apr 23, 2013California Institute Of TechnologyMicrofluidic chemostat
US8445210May 21, 2013California Institute Of TechnologyMicrofabricated crossflow devices and methods
US8448824Feb 26, 2009May 28, 2013Tandem Diabetes Care, Inc.Slideable flow metering devices and related methods
US8450065Nov 30, 2011May 28, 2013Fluidigm CorporationCopy number variation determination, methods and systems
US8455258Feb 15, 2011Jun 4, 2013California Insitute Of TechnologyApparatus and methods for conducting assays and high throughput screening
US8473216Nov 30, 2007Jun 25, 2013Fluidigm CorporationMethod and program for performing baseline correction of amplification curves in a PCR experiment
US8475743Apr 13, 2009Jul 2, 2013Fluidigm CorporationMultilevel microfluidic systems and methods
US8512640Oct 5, 2011Aug 20, 2013Fluidigm CorporationOptical lens system and method for microfluidic devices
US8551787Jul 23, 2010Oct 8, 2013Fluidigm CorporationMicrofluidic devices and methods for binary mixing
US8591834Apr 4, 2012Nov 26, 2013Fluidigm CorporationHigh efficiency and high precision microfluidic devices and methods
US8592215Sep 29, 2011Nov 26, 2013California Institute Of TechnologyMicrofabricated crossflow devices and methods
US8600168Oct 5, 2011Dec 3, 2013Fluidigm CorporationMethods and systems for image processing of microfluidic devices
US8616227Jun 3, 2013Dec 31, 2013Fluidigm CorporationMultilevel microfluidic systems and methods
US8617488Aug 4, 2009Dec 31, 2013Fluidigm CorporationMicrofluidic mixing and reaction systems for high efficiency screening
US8650937Sep 18, 2009Feb 18, 2014Tandem Diabetes Care, Inc.Solute concentration measurement device and related methods
US8658367May 18, 2012Feb 25, 2014California Institute Of TechnologyMicrofabricated crossflow devices and methods
US8658368May 18, 2012Feb 25, 2014California Institute Of TechnologyMicrofabricated crossflow devices and methods
US8658418Jul 13, 2009Feb 25, 2014Fluidigm CorporationMicrofluidic particle-analysis systems
US8673645Sep 4, 2012Mar 18, 2014California Institute Of TechnologyApparatus and methods for conducting assays and high throughput screening
US8691010Apr 15, 2011Apr 8, 2014California Institute Of TechnologyMicrofluidic protein crystallography
US8695640Jan 27, 2012Apr 15, 2014California Institute Of TechnologyMicrofabricated elastomeric valve and pump systems
US8709152Aug 19, 2011Apr 29, 2014California Institute Of TechnologyMicrofluidic free interface diffusion techniques
US8709153Oct 24, 2011Apr 29, 2014California Institute Of TechnologyMicrofludic protein crystallography techniques
US8721968Sep 19, 2013May 13, 2014Fluidigm CorporationOptical lens system and method for microfluidic devices
US8758323Jul 29, 2010Jun 24, 2014Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8808640Jan 31, 2013Aug 19, 2014Fluidigm CorporationMethod and system for microfluidic device and imaging thereof
US8809238May 9, 2012Aug 19, 2014Fluidigm CorporationProbe based nucleic acid detection
US8828661Apr 24, 2007Sep 9, 2014Fluidigm CorporationMethods for detection and quantification of nucleic acid or protein targets in a sample
US8828663Mar 20, 2006Sep 9, 2014Fluidigm CorporationThermal reaction device and method for using the same
US8846183Oct 20, 2011Sep 30, 2014California Institute Of TechnologyMicrofabricated elastomeric valve and pump systems
US8849037Nov 4, 2013Sep 30, 2014Fluidigm CorporationMethods and systems for image processing of microfluidic devices
US8871446Oct 2, 2003Oct 28, 2014California Institute Of TechnologyMicrofluidic nucleic acid analysis
US8874273Feb 8, 2011Oct 28, 2014Fluidigm CorporationAnalysis engine and database for manipulating parameters for fluidic systems on a chip
US8906000Oct 18, 2007Dec 9, 2014The Invention Science Fund I, LlcInjectable controlled release fluid delivery system
US8926561Jul 29, 2010Jan 6, 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8926905Jul 9, 2013Jan 6, 2015Fluidigm CorporationOptical lens system and method for microfluidic devices
US8932461Jun 28, 2011Jan 13, 2015California Institute Of TechnologyMicrofluidic sieve valves
US8986253Aug 7, 2009Mar 24, 2015Tandem Diabetes Care, Inc.Two chamber pumps and related methods
US9039997Sep 29, 2010May 26, 2015Fluidigm CorporationMicrofluidic devices with removable cover and methods of fabrication and application
US9067047Oct 19, 2007Jun 30, 2015The Invention Science Fund I, LlcInjectable controlled release fluid delivery system
US9090934Jul 14, 2014Jul 28, 2015Fluidigm CorporationMethods for detection and quantification of nucleic acid or protein targets in a sample
US9103825Apr 21, 2010Aug 11, 2015Fluidigm CorporationMicrofluidic assay devices and methods
US9150913Jul 12, 2012Oct 6, 2015Fluidigm CorporationThermal reaction device and method for using the same
US9157116Feb 9, 2009Oct 13, 2015Fluidigm CorporationCombinatorial amplification and detection of nucleic acids
US9168531Mar 26, 2012Oct 27, 2015Fluidigm CorporationMethod for thermal cycling of microfluidic samples
US9176137Mar 17, 2014Nov 3, 2015California Institute Of TechnologyApparatus and methods for conducting assays and high throughput screening
US9182322Nov 27, 2013Nov 10, 2015Fluidigm CorporationMicrofluidic mixing and reaction systems for high efficiency screening
US9205468Nov 30, 2010Dec 8, 2015Fluidigm CorporationMicrofluidic device regeneration
US9211377Jul 29, 2010Dec 15, 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9234237Nov 19, 2014Jan 12, 2016Fluidigm CorporationOptical lens system and method for microfluidic devices
US20050053952 *Oct 2, 2003Mar 10, 2005California Institute Of TechnologyMicrofluidic nucleic acid analysis
US20050072946 *Aug 10, 2004Apr 7, 2005California Institute Of TechnologyMicrofluidic large scale integration
US20070209574 *May 15, 2007Sep 13, 2007California Institute Of TechnologyMicrofluidic protein crystallography techniques
US20080108063 *Apr 24, 2007May 8, 2008Fluidigm CorporationAssay Methods
US20080129736 *Nov 30, 2007Jun 5, 2008Fluidigm CorporationMethod and apparatus for biological sample analysis
US20080223721 *Jan 22, 2008Sep 18, 2008Fluidigm CorporationHigh Efficiency and High Precision Microfluidic Devices and Methods
US20080281090 *Dec 5, 2005Nov 13, 2008California Institute Of TechnologyMicrofluidic Chemical Reaction Circuits
US20090069194 *Sep 8, 2008Mar 12, 2009Fluidigm CorporationCopy number variation determination, methods and systems
US20090137874 *Nov 26, 2007May 28, 2009The Hong Kong Polytechnic UniversityPolymer Microvalve with actuators and devices
US20090227988 *Oct 19, 2007Sep 10, 2009Searete Llc, A Limited Liability Corporation Of Th State Of DelawareInjectable controlled release fluid delivery system
US20090259176 *Apr 9, 2008Oct 15, 2009Los Gatos Research, Inc.Transdermal patch system
US20100175767 *Jul 15, 2010California Institute Of TechnologyMicrofabricated Elastomeric Valve and Pump Systems
US20100183481 *Oct 5, 2009Jul 22, 2010Fluidigm CorporationDevices And Methods For Holding Microfluidic Devices
US20100187105 *Sep 9, 2009Jul 29, 2010California Institute Of TechnologyMicrofabricated Elastomeric Valve And Pump Systems
US20100197522 *Aug 5, 2010California Institute Of TechnologyMicrofluidic Chaotic Mixing Systems And Methods
US20100230613 *Sep 16, 2010Fluidigm CorporationMicrofluidic devices and methods
US20100263732 *Apr 16, 2010Oct 21, 2010California Institute Of TechnologyMicrofluidic Free Interface Diffusion Techniques
US20100311060 *Dec 9, 2010Fluidigm CorporationIntegrated Chip Carriers With Thermocycler Interfaces And Methods Of Using The Same
US20100320364 *Aug 24, 2010Dec 23, 2010Fluidigm CorporationOptical lens system and method for microfluidic devices
US20110020918 *Apr 21, 2010Jan 27, 2011Fluidigm CorporationMicrofluidic Assay Devices And Methods
US20110126910 *Jul 23, 2010Jun 2, 2011Fluidigm CorporationMicrofluidic devices and methods for binary mixing
US20110151498 *Jun 23, 2011California Institute Of TechnologyApparatus and methods for conducting assays and high throughput screening
US20110229872 *Sep 22, 2011California Institute Of TechnologyMicrofabricated Cell Sorter
Classifications
U.S. Classification137/597, 251/61.1, 604/891.1
International ClassificationA61K9/22, F16K31/145, F16K11/20
Cooperative ClassificationY10T137/87249, Y10T137/88062, A61K9/0024, A61K9/0009, A61K9/703
European ClassificationA61K9/70E2, A61K9/00L8, A61K9/00M5D
Legal Events
DateCodeEventDescription
Jul 27, 2004ASAssignment
Owner name: FLUIDIGM CORPORATION, CALIFORNIA
Free format text: CORRECTIVE ASSIGNMENT TO CORRECT INCORRECT SERIAL NUMBER PREVIOUSLY RECORDED 07-12-04 ON REEL 014841 FRAME 0264;ASSIGNOR:NAT, AVTAR S.;REEL/FRAME:015608/0619
Effective date: 20031128
Jul 12, 2005ASAssignment
Oct 1, 2007ASAssignment
Owner name: FLUIDIGM CORPORATION - A DELAWARE CORPORATION,CALI
Free format text: REINCORPORATION ASSIGNMENT;ASSIGNOR:FLUIDIGM CORPORATION - A CALIFORNIA CORPORATION;REEL/FRAME:019899/0313
Effective date: 20070928
Dec 14, 2009FPAYFee payment
Year of fee payment: 4
Dec 13, 2013FPAYFee payment
Year of fee payment: 8